| Report ID | 279078 |
| Drug Identification Number | 02215756 |
| Brand name | CAVERJECT STERILE POWDER |
| Common or Proper name | CAVERJECT |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALPROSTADIL |
| Strength(s) | 20MCG |
| Dosage form(s) | POWDER FOR SOLUTION LIQUID KIT |
| Route of administration | INTRACAVERNOSAL INTRACAVERNOSAL |
| Packaging size | 5 x 20mcg |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-08-30 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-26 | French | Compare |
| v1 | 2026-02-26 | English | Compare |
Showing 1 to 2 of 2